Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
301
Shortening of mTL anticipates accumulation of DDR markers, decrease in cell proliferation and increase in apoptotis with age.
Published 2016“…Proliferative tissues, A) gut B) kidney marrow and C) testis, show a sustained decrease in cell proliferation by 12 months of age in <i>tert</i><sup><i>-/-</i></sup> (panels g, i) and by 36 months in WT tissues (panels f, h and j). …”
-
302
Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em><sub>g</sub> levels
Published 2013“…</strong> Likelihood of a decrease in runoff (a), an increase in runoff (b) and a severe change in ecosystems (c) for selected Δ<em>T</em><sub>g</sub> levels. …”
-
303
-
304
-
305
-
306
-
307
-
308
-
309
rAd-p53 induces apoptosis in HCC cell lines with increased Fbxw7 and decreased c-Myc and Cyclin E.
Published 2013“…<p>A) MTT activity was measured after infecting Hep3B cells with rAd-p53 in an MOI gradient to determine their IC<sub>50</sub> after 48 h. …”
-
310
-
311
-
312
-
313
-
314
Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.
Published 2016“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
-
315
-
316
-
317
-
318
-
319
-
320